These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 12682637
1. A flow cytometric method to detect apoptosis-related protein expression in minimal residual disease in acute myeloid leukemia. van Stijn A, Kok A, van der Pol MA, Feller N, Roemen GM, Westra AH, Ossenkoppele GJ, Schuurhuis GJ. Leukemia; 2003 Apr; 17(4):780-6. PubMed ID: 12682637 [Abstract] [Full Text] [Related]
2. Multiparameter flow cytometric quantification of apoptosis-related protein expression. van Stijn A, Kok A, van der Pol MA, Feller N, Roemen GM, Westra AH, Ossenkoppele GJ, Schuurhuis GJ. Leukemia; 2003 Apr; 17(4):787-8. PubMed ID: 12682638 [No Abstract] [Full Text] [Related]
3. Minimal residual disease in acute myeloid leukemia is predicted by an apoptosis-resistant protein profile at diagnosis. van Stijn A, Feller N, Kok A, van der Pol MA, Ossenkoppele GJ, Schuurhuis GJ. Clin Cancer Res; 2005 Apr 01; 11(7):2540-6. PubMed ID: 15814631 [Abstract] [Full Text] [Related]
4. Differences between the CD34+ and CD34- blast compartments in apoptosis resistance in acute myeloid leukemia. van Stijn A, van der Pol MA, Kok A, Bontje PM, Roemen GM, Beelen RH, Ossenkoppele GJ, Schuurhuis GJ. Haematologica; 2003 May 01; 88(5):497-508. PubMed ID: 12745269 [Abstract] [Full Text] [Related]
5. miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia. Ovcharenko D, Stölzel F, Poitz D, Fierro F, Schaich M, Neubauer A, Kelnar K, Davison T, Müller-Tidow C, Thiede C, Bornhäuser M, Ehninger G, Brown D, Illmer T. Exp Hematol; 2011 Oct 01; 39(10):1030-1042.e7. PubMed ID: 21784052 [Abstract] [Full Text] [Related]
6. The role of BCL-2 and bax protein in monocyte-mediated apoptosis in human leukemic cell lines. Legdeur MC, Bontje PM, Ossenkoppele GJ, Beelen RH, van de Loosdrecht AA, Broekhoven MG, Langenhuijsen MM, Thijsen SF, Hofstee H, Schuurhuis GJ. Exp Hematol; 1996 Nov 01; 24(13):1530-9. PubMed ID: 8950237 [Abstract] [Full Text] [Related]
8. The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia. Zelezníková T, Babusíková O. Neoplasma; 2006 Nov 01; 53(6):500-6. PubMed ID: 17167719 [Abstract] [Full Text] [Related]
9. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes. Suárez L, Vidriales MB, García-Laraña J, Sanz G, Moreno MJ, López A, Barrena S, Martínez R, Tormo M, Palomera L, Lavilla E, López-Berges MC, de Santiago M, de Equiza ME, Miguel JF, Orfao A. Clin Cancer Res; 2004 Nov 15; 10(22):7599-606. PubMed ID: 15569991 [Abstract] [Full Text] [Related]
10. Regulation of bcl-2, bcl-XL and bax in the control of apoptosis by hematopoietic cytokines and dexamethasone. Lotem J, Sachs L. Cell Growth Differ; 1995 Jun 15; 6(6):647-53. PubMed ID: 7669718 [Abstract] [Full Text] [Related]
11. Expression of Bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid. Andreeff M, Jiang S, Zhang X, Konopleva M, Estrov Z, Snell VE, Xie Z, Okcu MF, Sanchez-Williams G, Dong J, Estey EH, Champlin RC, Kornblau SM, Reed JC, Zhao S. Leukemia; 1999 Nov 15; 13(11):1881-92. PubMed ID: 10557066 [Abstract] [Full Text] [Related]
12. p53 pathway in apoptosis induced by all-trans-retinoic acid in acute myeloblastic leukaemia cells. Zheng A, Mäntymaa P, Säily M, Savolainen E, Vähäkangas K, Koistinen P. Acta Haematol; 2000 Nov 15; 103(3):135-43. PubMed ID: 10940651 [Abstract] [Full Text] [Related]
14. Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins. Konopleva M, Konoplev S, Hu W, Zaritskey AY, Afanasiev BV, Andreeff M. Leukemia; 2002 Sep 15; 16(9):1713-24. PubMed ID: 12200686 [Abstract] [Full Text] [Related]
15. The prognostic value of Bcl-XL gene expression for remission induction is influenced by cytogenetics in adult acute myeloid leukemia. Schaich M, Illmer T, Seitz G, Mohr B, Schäkel U, Beck JF, Ehninger G. Haematologica; 2001 May 15; 86(5):470-7. PubMed ID: 11410409 [Abstract] [Full Text] [Related]
16. Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia. Suárez L, Vidriales B, García-Laraña J, López A, Martínez R, Martín-Reina V, Tormo M, González-San Miguel JD, Lavilla E, García-Boyero R, Orfao A, San Miguel JF, PETHEMA Cooperative Group. Haematologica; 2001 Dec 15; 86(12):1287-95. PubMed ID: 11726321 [Abstract] [Full Text] [Related]
17. High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia. Tamm I, Richter S, Oltersdorf D, Creutzig U, Harbott J, Scholz F, Karawajew L, Ludwig WD, Wuchter C. Clin Cancer Res; 2004 Jun 01; 10(11):3737-44. PubMed ID: 15173080 [Abstract] [Full Text] [Related]
18. Ajoene, a garlic-derived natural compound, enhances chemotherapy-induced apoptosis in human myeloid leukaemia CD34-positive resistant cells. Ahmed N, Laverick L, Sammons J, Zhang H, Maslin DJ, Hassan HT. Anticancer Res; 2001 Jun 01; 21(5):3519-23. PubMed ID: 11848518 [Abstract] [Full Text] [Related]
19. Minimal residual disease cells in AML patients have an apoptosis-sensitive protein profile. van Stijn A, Kok A, van Stalborch MA, van Der Pol MA, Feller N, Westra AH, Ossenkoppele GJ, Schuurhuis GJ. Leukemia; 2004 Apr 01; 18(4):875-7. PubMed ID: 14762445 [No Abstract] [Full Text] [Related]
20. Apoptosis and expression of apoptosis regulating proteins bcl-2, mcl-1, bcl-X, and bax in malignant mesothelioma. Soini Y, Kinnula V, Kaarteenaho-Wiik R, Kurttila E, Linnainmaa K, Pääkkö P. Clin Cancer Res; 1999 Nov 01; 5(11):3508-15. PubMed ID: 10589765 [Abstract] [Full Text] [Related] Page: [Next] [New Search]